联影医疗 / United Imaging: 75 CE-certified products and 51% overseas revenue growth in a year

联影医疗 / United Imaging Healthcare — a Chinese manufacturer of medical imaging equipment (CT, MRI, PET) — grew overseas revenue to RMB 3.43 billion in 2025, up 51.39% year over year, according to the company's financial disclosures. The company's presence now spans more than 100 countries and regions, with regional service centers in 12 of them.

Regulatory footprint as a marker of serious intent

By the end of 2025, United Imaging had launched more than 150 products, including 75 with EU CE certification and 58 cleared by the US FDA via the 510(k) pathway. Over 20 products received FDA clearance as AI-enabled devices — meaning this isn't simple compliance with baseline requirements, but a full regulatory review cycle in key markets, including the most demanding US one.

A service network, not just equipment sales

The company's overseas service sites grew to 44, and its global spare-parts warehouse network expanded to 39 locations. For medical equipment at this level, that's a critical detail: a scanner costing hundreds of thousands of dollars is useless to a hospital without guaranteed servicing and parts availability — which is exactly why United Imaging invests in support infrastructure alongside sales expansion.

Notable success in Europe

Revenue in Europe grew nearly 50% year over year, and in early 2026 the company received CE certification for an entire product line, including a landmark achievement — approval of its radiotherapy (RT) systems. That's a separate equipment category requiring especially strict certification due to its direct patient impact, and clearing it successfully is a strong signal of technological maturity for prospective hospital buyers.

An overview of China's medtech manufacturers is covered in the longevity and biotech program; a full company catalog is available on the GlobalTechTour site.